CSIRO's research is focused on the following

Australian Animal Health Laboratory
Australian Animal Health Laboratory

- The Australian Animal Health Laboratory (AAHL) is a front line defence – helping to protect Australia from the threat of exotic and emerging animal diseases.

Australian Biotech Growth Partnerships
Australian Biotech Growth Partnerships

- CSIRO's Australian Biotech Growth Partnerships supports the growth of the biotechnology industry and is currently working with over 50 companies.

Bio21 Collaborative Crystallisation Centre
Bio21 Collaborative Crystallisation Centre

- Our Collaborative Crystallisation Centre (C3) provides high throughput screening and optimisation of crystallisation conditions for proteins and protein complexes.

Carbon Nanotube Yarn
Carbon Nanotube Yarn

- CSIRO research is supporting the development of revolutionary new products and processes in medicine, environmental management and energy.

Electrospinning creates ultra-fine fibres
Electrospinning creates ultra-fine fibres

- Experimental textiles produced by electrospinning are being assessed for medical, industrial and environmental applications.

Fluid Dynamics
Fluid Dynamics

- CSIRO's biofluid dynamics team is successfully applying their skills to develop original devices and to support industries involved in medical devices, diagnostics and treatment.

RAFT technologies
RAFT technologies

- RAFT: a process for making better polymers.

Working closely with industry partners, CSIRO collaborates on product and technology developments for health and medical related outcomes.

CSIRO draws upon the expertise of chemists, biologists, physicists, engineers and material scientists to address key challenges in health. Our focus is on developing new ‘smart’ technologies which offer platform opportunities where specific parts of the technology can be adapted to many end uses in health and medicine.